Skip to content
MedsAcross

Medicine

Hydroxychloroquine 300 mg tablet

Available on requestPrescription onlyUS FDAGeneric name

Hydroxychloroquine 300 mg tablet is a generic prescription medicine for oral use, made by 3 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at room temperature [20°C to 25°C (68°F to 77°F), allows excursions…

Key facts

Active ingredient (INN)
Hydroxychloroquine
Brand
Sold under the generic name
Strength
300 mg
Dosage form
Tablet
Route
Oral
Packs
100 tablets, 500 tablets, 30 tablets and 2 more
Manufacturers
Dr. Reddy's LaboratoriesIndiaAccord HealthcareIndiaBryant Ranch Prepack
Origin register
US FDA, United States
Storage
Store at room temperature [20°C to 25°C (68°F to 77°F), allows excursions between 15°C and 30°C (59°F and 86°F)]. Storage Dispense in a tight, light-resistant container as defined in the USP/NF.
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
P01BA02 Hydroxychloroquine
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
28 September 2021
Identifiers
RxCUI 2569283, 979092, 1119312 +1DailyMed set ID 2c109188-d28b-4c65-8b52-819bd8547f2e, 84b00366-96ef-41e1-bac6-5d24acdb9e1d, 452092b4-7a8f-4d19-8113-f1c2a948d3d8NDC 63629-4465, 16729-562, 43598-132Application ANDA210441, ANDA213342

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
100 tablet in 1 bottle16729-562-01Accord HealthcareIndia28 September 2021
100 tablet, film coated in 1 bottle43598-132-01Dr. Reddy's LaboratoriesIndia24 October 2022
500 tablet, film coated in 1 bottle43598-132-05Dr. Reddy's LaboratoriesIndia24 October 2022
30 tablet in 1 bottle63629-4465-1Bryant Ranch Prepack16 August 2024
14 tablet in 1 bottle63629-4465-2Bryant Ranch Prepack16 August 2024

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 18 April 1955Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Alternatives

Other makers and brands of Hydroxychloroquine 300 mg tablet.

Compare 1

Other strengths and forms of Hydroxychloroquine

Clinical summary

Hydroxychloroquine is an antimalarial indicated for the treatment of uncomplicated malaria due to Plasmodium falciparum, Plasmodium malariae, Plasmodium ovale, and Plasmodium vivax in adult and pediatric patients, among other approved uses. MedsAcross supplies Hydroxychloroquine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Hydroxychloroquine

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Hydroxychloroquine 300 mg tablet for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.